| Style | Citing Format |
|---|---|
| MLA | Doroodgar F, et al.. "Inflammatory and Genomic Interactions Within Keratoconus Susceptible Patients: A Nationwide Registered Case–Control Study." Eye and Vision, vol. 11, no. 1, 2024, pp. -. |
| APA | Doroodgar F, Alizadeh F, Niazi S, Razavi SM, Jalilian N, Azarnezhad A, Niazi F, Javadi MA, Del Barrio JA, Dehghani S, Moshirfar M, Gatzioufas Z, Alio JL (2024). Inflammatory and Genomic Interactions Within Keratoconus Susceptible Patients: A Nationwide Registered Case–Control Study. Eye and Vision, 11(1), -. |
| Chicago | Doroodgar F, Alizadeh F, Niazi S, Razavi SM, Jalilian N, Azarnezhad A, Niazi F, et al.. "Inflammatory and Genomic Interactions Within Keratoconus Susceptible Patients: A Nationwide Registered Case–Control Study." Eye and Vision 11, no. 1 (2024): -. |
| Harvard | Doroodgar F et al. (2024) 'Inflammatory and Genomic Interactions Within Keratoconus Susceptible Patients: A Nationwide Registered Case–Control Study', Eye and Vision, 11(1), pp. -. |
| Vancouver | Doroodgar F, Alizadeh F, Niazi S, Razavi SM, Jalilian N, Azarnezhad A, et al.. Inflammatory and Genomic Interactions Within Keratoconus Susceptible Patients: A Nationwide Registered Case–Control Study. Eye and Vision. 2024;11(1):-. |
| BibTex | @article{ author = {Doroodgar F and Alizadeh F and Niazi S and Razavi SM and Jalilian N and Azarnezhad A and Niazi F and Javadi MA and Del Barrio JA and Dehghani S and Moshirfar M and Gatzioufas Z and Alio JL}, title = {Inflammatory and Genomic Interactions Within Keratoconus Susceptible Patients: A Nationwide Registered Case–Control Study}, journal = {Eye and Vision}, volume = {11}, number = {1}, pages = {-}, year = {2024} } |
| RIS | TY - JOUR AU - Doroodgar F AU - Alizadeh F AU - Niazi S AU - Razavi SM AU - Jalilian N AU - Azarnezhad A AU - Niazi F AU - Javadi MA AU - Del Barrio JA AU - Dehghani S AU - Moshirfar M AU - Gatzioufas Z AU - Alio JL TI - Inflammatory and Genomic Interactions Within Keratoconus Susceptible Patients: A Nationwide Registered Case–Control Study JO - Eye and Vision VL - 11 IS - 1 SP - EP - PY - 2024 ER - |